Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2596 AL 2610

Antimicrobial drugs for Parkinson's disease: Existing therapeutic strategies and novel drugs exploration

Fu M, Wang Q, Gao L, Yuan X, Wang J.

Ageing Res Rev. 2024 Aug;99:102387. doi: 10.1016/j.arr.2024.102387. Epub 2024 Jun 26.

Cognition and Activity of Daily Living Function in people with Parkinson's disease

Bode M, Kalbe E, Liepelt-Scarfone I.

J Neural Transm (Vienna). 2024 Oct;131(10):1159-1186. doi: 10.1007/s00702-024-02796-w. Epub 2024 Jul 8.

Assessing the prevalence and risk of tooth wear in Parkinson's disease: A narrative review

Verhoeff MC, Wetselaar P, Lobbezoo F.

Dent Med Probl. 2024 Sep-Oct;61(5):759-764. doi: 10.17219/dmp/183842.

Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease

Verma A, Goyal A.

Eur J Pharmacol. 2024 Nov 5;982:176936. doi: 10.1016/j.ejphar.2024.176936. Epub 2024 Aug 23.

Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease

Crispo JAG, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan RL, Habash M, Gogna P, Kelly SE, Elliott J, Kohen DE, Bjerre LM, Mattison DR, Hessian RC, Willis AW, Krewski D.

Brain Sci. 2024 Jul 31;14(8):776. doi: 10.3390/brainsci14080776.

What is known about the challenges people with Parkinson's disease experience with their medicines and what solutions have been explored to overcome them? A scoping review

Jones S, Patel JP, Twigg MJ, Chaudhuri KR.

Int J Pharm Pract. 2024 Nov 14;32(6):431-445. doi: 10.1093/ijpp/riae051.

Emerging Gene Therapies for Alzheimer's and Parkinson's Diseases: An Overview of Clinical Trials and Promising Candidates

Roberts WS, Price S, Wu M, Parmar MS.

Cureus. 2024 Aug 16;16(8):e67037. doi: 10.7759/cureus.67037. eCollection 2024 Aug.

Improving Healing: The Putative Effects of Low-Level Laser Therapy for Ulcer in Parkinson's Disease

Sasun AR, Phansopkar P, Qureshi MI.

Cureus. 2024 Mar 23;16(3):e56756. doi: 10.7759/cureus.56756. eCollection 2024 Mar.

A comprehensive examination of the evidence for whole of diet patterns in Parkinson's disease: a scoping review

Rees J, Ryan J, Laws M, Devine A.

Nutr Neurosci. 2024 Jun;27(6):547-565. doi: 10.1080/1028415X.2023.2233727. Epub 2023 Jul 10.

Emerging Role of Long Noncoding RNAs in Regulating Inflammasome-Mediated Neurodegeneration in Parkinson's Disease

Sivagurunathan N, Rahamathulla MP, Al-Dossary H, Calivarathan L.

Mol Neurobiol. 2024 Jul;61(7):4619-4632. doi: 10.1007/s12035-023-03809-7. Epub 2023 Dec 18.

Genetics in Parkinson's disease, state-of-the-art and future perspectives

Trevisan L, Gaudio A, Monfrini E, Avanzino L, Di Fonzo A, Mandich P.

Br Med Bull. 2024 Mar 13;149(1):60-71. doi: 10.1093/bmb/ldad035.

Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder

Thomas SD, Abdalla S, Eissa N, Akour A, Jha NK, Ojha S, Sadek B.

Pharmaceuticals (Basel). 2024 Jun 25;17(7):831. doi: 10.3390/ph17070831.

Neuroinflammation-mediated white matter injury in Parkinson's disease and potential therapeutic strategies targeting NLRP3 inflammasome

Xiao L, Wang M, Shi Y, Huang X, Zhang W, Wu Y, Deng H, Xiong B, Pan W, Zhang J, Wang W.

Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113483. doi: 10.1016/j.intimp.2024.113483. Epub 2024 Nov 2.

The Role of Virtual Reality in Postural Rehabilitation for Patients with Parkinson's Disease: A Scoping Review

Agostini F, Conti M, Morone G, Iudicelli G, Fisicaro A, Savina A, Mangone M, Paoloni M.

Brain Sci. 2024 Dec 29;15(1):23. doi: 10.3390/brainsci15010023.

Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review

Bansal K, Singh V, Singh S, Mishra S.

Curr Mol Med. 2024;24(3):316-326. doi: 10.2174/1566524023666230320144722.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias